CLINICAL TRIALS

Clinical trials help researchers find better ways to detect, treat, and understand prostate cancer. These studies are carefully designed to test new tools, treatments, or ways of caring for patients. Every treatment that is now approved, like surgery, radiation, and medications, was first studied in a clinical trial.

You may be eligible to join a clinical trial at any stage of prostate cancer. Some trials focus on:

• Early stage disease, testing new imaging tools, surgical techniques, radiation options, or combinations of these with new medications

• Biochemically recurrent prostate cancer, where PSA levels rise after treatment but there is no visible cancer yet. Trials here may test next generation scans or hormone therapy timing

• Advanced or metastatic prostate cancer, offering access to new medications, immunotherapies, or targeted treatments that aim to slow the cancer’s spread or improve quality of life

• Genetic and biomarker research, which can help match treatments to your specific type of prostate cancer. This can include tissue or blood tests that reveal how aggressive the cancer may be or which drugs might work best

Participating in a trial is always your choice. You can leave at any time. Trials follow strict safety rules, and many offer close monitoring and extra support. While not all trials guarantee better results, they give you access to care that is not yet widely available and help future patients as well.

If you are interested in learning more, talk to your doctor. They can help you find trials that fit your specific diagnosis and treatment goals.

You can also visit here to search a list of all active clinical trials related to prostate cancer/prostate conditions on clinicaltrials.gov.